Globe Newswire 30-Sep-2025 5:00 PM

NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors about a federal securities class action lawsuit Semler Scientific, Inc. (NASDAQ:SMLR) ("Semler" or the "Company").

PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION

Semler Scientific (NASDAQ:SMLR) Securities Class Action Summary

• Court: United States District Court for the Northern District of California
• Class Period: March 10, 2021 – April 15, 2025
• Allegations: The filed complaint alleges that Semler Scientific and its executives made false and/or misleading statements and failed to disclose:
  
  
  
  
  1. That the company was under a material investigation by the U.S. Department of Justice (DOJ) for potential False Claims Act violations.
     
     
  2. While discussing potential violations of the False Claims Act publicly, they spoke only in hypothetical terms, despite the DOJ's active investigation.
  3. As a result, investors were allegedly misled, and the company's public statements were materially false and/or misleading throughout the class period.
     
     

Next Steps for Investors: Shareholders who suffered losses can seek appointment as lead plaintiff prior to October 28, 2025 by contacting Wolf Haldenstein.

Why Wolf Haldenstein Adler Freeman & Herz LLP?:

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

Contact:

• Phone: (800) 575-0735 or (212) 545-4774
• Email: classmember@whafh.com
• Contact Person: Gregory Stone, Director of Case and Financial Analysis
  
  

Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.